According to the data, according to the needs of epidemic prevention and control, in order to further ensure the supply of antigen detection reagents for epidemic prevention and control in COVID-19, the State Administration of Medical Products issued the Announcement on Extending the Validity Period of COVID-19 Antigen Detection Reagent Registration Certificate (114,2022) on February 8, 65438, which extended the validity period of COVID-19 Antigen Detection Reagent Registration Certificate which had been approved for registration by six months on the basis of the original validity period, effectively protecting the relevant product market.
In addition, on February 9, 65438, the State Pharmaceutical Products Supervision and Administration approved three kinds of COVID-19 antigen detection reagent products from three companies: Biotech (Wuhan) Co., Ltd., Ji Dan Biotechnology Co., Ltd. and Taipu Biotechnology (China) Co., Ltd.
65438+February 1 1, COVID-19 antigen detection reagent product of Zhongshan Bioengineering Co., Ltd. was approved by the State Medical Supplies Administration.
The State Administration of Pharmaceutical Products said that the drug supervision and administration department will strengthen the post-marketing supervision of related products to ensure the safety of patients' devices.